Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Waldenstrom Macroglobulinemia

Known as: Macroglobulinemia, macroglobulinaemia, Lymphomas, Lymphoplasmacytoid 
A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Proteasome inhibitors are one of the most important classes of agents to have emerged for the treatment of multiple myeloma in… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND MYD88(L265P) and CXCR4(WHIM) mutations are highly prevalent in Waldenström's macroglobulinemia. MYD88(L265P) triggers… Expand
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND Waldenström's macroglobulinemia is an incurable, IgM-secreting lymphoplasmacytic lymphoma (LPL). The underlying… Expand
  • figure 1
  • figure 2
Is this relevant?
Review
2010
Review
2010
Waldenström macroglobulinemia is a B-cell malignancy with lymphoplasmacytic infiltration in the bone marrow or lymphatic tissue… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Recently, many new drugs have been developed for the treatment of Waldenström macroglobulinemia (WM). To optimize the treatment… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2009
Review
2009
Waldenström macroglobulinemia (WM) is a distinct B-cell disorder resulting from the accumulation, predominantly in the bone… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE We examined the activity of bortezomib, dexamethasone, and rituximab (BDR) in patients with symptomatic, untreated… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Review
2003
Review
2003
This presentation represents consensus recommendations for the clinicopathological definition of Waldenstrom's macroglobulinemia… Expand
Is this relevant?
Review
2003
Review
2003
This presentation represents consensus recommendations on prognostic markers and criteria to initiate therapy in patients with… Expand
  • table 1
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE Waldenström's macroglobulinemia (WM) is a low-grade lymphoplasmacytic lymphoma in which CD20 is usually expressed on… Expand
Is this relevant?